Inovio Pharmaceuticals, Inc. - Common Stock (INO)
1.3300
-0.8100 (-37.85%)
NASDAQ · Last Trade: Jul 4th, 7:55 PM EDT
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · July 4, 2025
Via Benzinga · July 3, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · July 3, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.
Via Chartmill · July 3, 2025
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · July 3, 2025
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · July 3, 2025
Via Benzinga · July 3, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · July 3, 2025
Via Benzinga · July 3, 2025
Via Benzinga · July 3, 2025
Via Benzinga · July 2, 2025
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · July 2, 2025
INO earnings call for the period ending December 31, 2024.
Via The Motley Fool · March 18, 2025

Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday's session. The decline may be attributed to profit-taking, as investors assess renewed focus on respiratory illnesses.
Via Benzinga · January 8, 2025

Inovio Pharmaceuticals shares are trading higher by 20.7% Tuesday afternoon. Vaccine stocks are rising amid growing concerns about respiratory illnesses.
Via Benzinga · January 7, 2025

Via Benzinga · December 13, 2024

Via Benzinga · December 13, 2024

Via Benzinga · December 13, 2024

Via Benzinga · December 13, 2024